Dr Dushianthan is a consultant in respiratory medicine and the general intensive care unit (GICU).

MBBS MRCP FFICM PhD

Specialty

Respiratory, critical care and general medicine

Sub-specialty

Non-invasive ventilation (breathing support that doesn't need intubation or a tracheostomy)

Training and education

Graduate of St Bartholomew’s and Royal London School of Medicine
MRCP (Royal College of Physicians)
MRCP respiratory medicine
PhD from the University of Southampton
Fellowship of the Faculty of Intensive Care Medicine (FFICM)
Triple accreditation in intensive care, respiratory and general medicine

Experience

Dr Dushianthan is a consultant in respiratory medicine and the general intensive care unit (GICU). He joined the Trust in 2016.

His clinical work includes the assessment and management of critically ill patients in GICU. He also works as a general chest physician managing patients in the respiratory wards and respiratory high dependency unit.

His special interests include non-invasive ventilation for acute and chronic respiratory conditions and acute respiratory distress syndrome (ARDS), a condition where the lungs can't provide enough oxygen for the body's vital organs.

Awards and prizes

Welsh Thoracic Society Publication Prize 2012
BJA/RCoA award 2012

Research

Dr Dushianthan's research interests include:

surfactant biology, cellular membrane phospholipids and dynamic synthetic pathways in acute respiratory distress syndrome (ARDS)
perioperative and critical illness intravenous fluid therapy
nutritional modifications of phospholipids metabolic pathways in critical illness.

Key publications

Dushianthan A, Cusack R, Grocott MPW, Postle AD. Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome. Journal of Lipid Research 2018; 59 (6): 1034-1045
Bampoe S, Odor PM, Dushianthan A, Bennett‐Guerrero E, Cro S, Gan TJ, Grocott MPW, James MFM, Mythen MG, O'Malley C, Roche AM, Rowan K, Burdett E. Perioperative administration of buffered versus non‐buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures. Cochrane Database of Systematic Reviews 2017, Issue 9.CD004089.pub3
McAuley DF, Cross LJM, Hamid U, Gardner E, Elborn JS, Cullen KM, Dushianthan A, Grocott MPW, Matthay MA, O'Kane CM. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Respiratory Medicine 2017; 5 (6): 484-491
Dushianthan A, Goss V, Cusack R, Grocott MP, Postle AD. Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers. BMC Pulmonary Medicine 2014;14:10.
Dushianthan A, Cusack R, Chee N, Dunn JO, Grocott MP. Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians. BMC Anaesthesiology 2014;14:87.
Dushianthan A, Goss V, Cusack R, Grocott MP, Postle AD. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome. Respiratory Research 2014;15:128.
Grocott MPW, Dushianthan A, Hamilton MA, Mythen MG, Harrison D, Rowan K and The Optimisation Steering Group. Peri-operative increase in global blood flow to explicit defined goals and outcomes following surgery- a Cochrane Systematic Review. British Journal of Anaesthesia 2013; 111(4):535-48.
Dushianthan A, Cusack R, Goss V, Postle AD, Grocott MPW. Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome – where do we go from here? Critical Care 2012; 16 (6):238.
Grocott MPW, Dushianthan A, Hamilton MA, Mythen MG, Harrison D, Rowan K and The Optimisation Steering Group. Peri-operative increase in global blood flow to explicit defined goals and outcomes following surgery. Cochrane Database Syst Rev 2012 14;11: CD004082.
Dushianthan A, Grocott MP, Postle AD, Cusack R. Acute Respiratory distress Syndrome and Acute Lung Injury. Postgraduate Medical Journal 2011;87(1031):612-22.

Contact

To contact Dr Ahilanadan Dushianthan, please call Angela Flux on 023 8120 2382 or Louise England and Helen Hewson on 023 8120 6135.